Fu Bao, the beloved first giant panda born in South Korea, made her comeback on Tuesday at the Shenshuping giant panda base ...
Fubao set to reappear at Chengdu Panda Base after four-month recovery period Fubaos health significantly improved during its ...
Pharmaceutical Technology on MSN1d
AstraZeneca to invest $2.5bn in R&D centre in ChinaThe new centre will focus on early-stage research and clinical development, supported by data science and AI labs.
Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and milestones combined, with Chinese companies Harbour Biomed Ltd. and Syneron ...
Transfer learning, as a new machine learning methodology, may solve problems in related but different domains by using ...
The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...
Beginning construction in 2019, the center was jointly initiated by Peking University and the Institute of Biophysics, and ...
Beijing on Thursday demanded protections for Chinese students in the U.S. after a Congressional panel asked six American universities to hand over a large amount of detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback